This article was originally published in The Gray Sheet
Executive SummaryMedicare Payment Advisory Commission's membership would be expanded from 17 to 19 members and include "individuals with national recognition for their expertise in manufacturing and distributing finished medical goods" under a bill (S 1529) introduced Aug. 5 by Sen. Bill Frist (R-Tenn.). The legislation states that Medicare "has struggled to keep up with the latest technologies and medical supply products, even if such technologies and products prove to be cost-effective." MEDPAC is required to submit an annual report to Congress with recommendations on Medicare
You may also be interested in...
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.